Details der Publikation - ?Effect of sofosbuvir/ ledipasvir on COVID-19

Medienart:	Klinische Studie

Erscheinungsjahr:	2020
Erschienen:	2020

Enthalten in:	WHO International Clinical Trials Registry Platform - (2020) vom: 21. Apr. Zur Gesamtaufnahme - year:2020

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: COVID-19 pneumonia. Phase: Phase 2/Phase 3 Recruitment Status: Recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-03-19, Last updated: 2022-11-24

ICTRP ID:	IRCT20100228003449N29

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	WHO005100496


LEADER	01000caa a22002652 4500
001	WHO005100496
003	DE-627
005	20230425170210.0
007	cr uuu---uuuuu
008	210507s2020 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)WHO005100496
035			\|a (UBBS_Klinische_Studien_WHO)IRCT20100228003449N29
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a ?Effect of sofosbuvir/ ledipasvir on COVID-19 \|b Evaluating efficacy and safety of sofosbuvir/ ledipasvir in treatment of COVID-19
264		1	\|c 2020
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-03-19, Last updated: 2022-11-24
650		4	\|a Medical Condition: COVID-19 pneumonia.
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 2/Phase 3
650		4	\|a Recruitment Status: Recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2020) vom: 21. Apr.
773	1	8	\|g year:2020 \|g day:21 \|g month:04
856	4	0	\|u http://en.irct.ir/trial/46567 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2020 \|b 21 \|c 04